Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice

European Journal of Immunology

Volumn 44, Issue 8, 2014, Pages 2405-2414

  Quintin, Jessica ^a   Voigt, Jessica ^b   van der Voort, Robbert ^a   Jacobsen, Ilse D ^c   Verschueren, Ineke ^a   Hube, Bernhard ^b,c,d   Giamarellos Bourboulis, Evangelos J ^d   van der Meer, Jos W M ^a   Joosten, Leo A B ^a   Kurzai, Oliver ^b   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c HANS KNÖLL INSTITUTE   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Candida albicans; Host defense; NK cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CANDIDA ALBICANS; CAUSE OF DEATH; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FUNCTIONAL STATUS; FUNGUS GROWTH; FUNGUS HYPHAE; HEPATITIS; HOST RESISTANCE; IMMUNE RESPONSE; IN VIVO STUDY; INVASIVE CANDIDIASIS; KIDNEY INFECTION; LIMIT OF QUANTITATION; LYMPHOCYTE DEPLETION; MICROBIAL ATTENUATION; MORTALITY; MOUSE; NATURAL KILLER CELL; NOD SCID GAMMA MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIMARY INFECTION; PRIORITY JOURNAL; SCID MOUSE; SECONDARY INFECTION; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE; TIME OF DEATH; TISSUE HOMOGENATE; UPREGULATION; YEAST CELL;

CANDIDA ALBICANS; HOST DEFENSE; NK CELLS;

ANIMALS; B-LYMPHOCYTES; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES;

EID: 84906093170     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343828     Document Type: Article

References (31)

1. Naglik, J. R., Fidel, P. L., Jr. and Odds, F. C., Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 2008. 283: 129-139.
2. Pfaller, M. A., Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin. Infect. Dis. 1996. 22(Suppl 2): S89-S94.
3. Pfaller, M. A. and Diekema, D. J., Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007. 20: 133-163.
4. Netea, M. G., Brown, G. D., Kullberg, B. J. and Gow, N. A., An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008. 6: 67-78.
5. Lortholary, O. and Dupont, B., Antifungal prophylaxis during neutropenia and immunodeficiency. Clin. Microbiol. Rev. 1997. 10: 477-504.
6. Marodi, L., Schreiber, S., Anderson, D. C., MacDermott, R. P., Korchak, H. M. and Johnston, R. B., Jr., Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 1993. 91: 2596-2601.
7. Ortega, E., Algarra, I., Serrano, M. J., Alvarez de Cienfuegos, G. and Gaforio, J. J., The use of 7-amino-actinomycin D in the analysis of Candida albicans phagocytosis and opsonization. J. Immunol. Methods 2001. 253: 189-193.
8. Deschamps, M. M., Pape, J. W., Verdier, R. I., DeHovitz, J., Thomas, F. and Johnson, W. D., Jr., Treatment of candida esophagitis in AIDS patients. Am. J. Gastroenterol. 1988. 83: 20-21.
9. Kirkpatrick, C. H., Chronic mucocutaneous candidiasis. Pediatr. Infect Dis. J. 2001. 20: 197-206.
10. Ortega, E., Algarra, I., Serrano, M. J., de Pablo, M. A., Alvarez de Cienfuegos, G. and Gaforio, J. J., Enhanced resistance to experimental systemic candidiasis in tilorone-treated mice. FEMS Immunol. Med. Microbiol. 2000. 28: 283-289.
11. Algarra, I., Ortega, E., Serrano, M. J., Alvarez de Cienfuegos, G. and Gaforio, J. J., Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol. Med. Microbiol. 2002. 33: 159-163.
12. Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Schiaffella, E., Tonnetti, L., Puccetti, P. et al., Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice. Infect. Immun. 1993. 61: 3769-3774.
13. Voigt, J., Hunniger, K., Bouzani, M., Jacobsen, I. D., Barz, D., Hube, B., Loffler, J. et al., Human natural killer cells acting as phagocytes against Candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity. J. Infect. Dis. 2014. 209: 616-626.
14. Laffont, S., Seillet, C., Ortaldo, J., Coudert, J. D. and Guery, J. C., Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008. 112: 661-671.
15. Bistoni, F., Cenci, E., Mencacci, A., Schiaffella, E., Mosci, P., Puccetti, P. and Romani, L., Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J. Infect. Dis. 1993. 168: 1449-1457.
16. Cenci, E., Mencacci, A., Spaccapelo, R., Tonnetti, L., Mosci, P., Enssle, K. H., Puccetti, P. et al., T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 1995. 171: 1279-1288.
17. Cenci, E., Mencacci, A., Del Sero, G., d'Ostiani, C. F., Mosci, P., Bacci, A., Montagnoli, C. et al., IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J. Immunol. 1998. 161: 3543-3550.
18. Balish, E., Warner, T., Pierson, C. J., Bock, D. M. and Wagner, R. D., Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 2001. 39: 261-268.
19. Cantorna, M. T. and Balish, E., Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 1990. 58: 1093-1100.
20. Cantorna, M. T. and Balish, E., Acquired immunity to systemic candidiasis in immunodeficient mice. J. Infect. Dis. 1991. 164: 936-943.
21. Zucchini, N., Crozat, K., Baranek, T., Robbins, S. H., Altfeld, M. and Dalod, M., Natural killer cells in immunodefense against infective agents. Expert Rev. Anti. Infect. Ther. 2008. 6: 867-885.
22. Gladiator, A., Wangler, N., Trautwein-Weidner, K. and LeibundGut-Landmann, S., Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 2013. 190: 521-525.
23. Hernandez-Santos, N., Huppler, A. R., Peterson, A. C., Khader, S. A., McKenna, K. C. and Gaffen, S. L., Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 2013. 6: 900-910.
24. Cua, D. J. and Tato, C. M., Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010. 10: 479-489.
25. Anwar, K. P., Malik, A. and Subhan, K. H., Profile of candidiasis in HIV infected patients. Iran J. Microbiol. 2012. 4: 204-209.
26. Altfeld, M., Fadda, L., Frleta, D. and Bhardwaj, N., DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 2011. 11: 176-186.
27. Quintin, J., Saeed, S., Martens, J. H., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., Jacobs, L. et al., Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012. 12: 223-232.
28. Lehrer, R. I. and Cline, M. J., Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 1969. 98: 996-1004.
29. Wozniok, I., Hornbach, A., Schmitt, C., Frosch, M., Einsele, H., Hube, B., Loffler, J. et al., Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Cell. Microbiol. 2008. 10: 807-820.
30. Kullberg, B. J., van't Wout, J. W. and van Furth, R., Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. 1990. 58: 3319-3324.
31. Netea, M. G., Demacker, P. N., Kullberg, B. J., Boerman, O. C., Verschueren, I., Stalenhoef, A. F. and van der Meer, J. W., Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J. Clin. Invest. 1996. 97: 1366-1372.